Mairead McGrattan1, Cristín Ryan2, Heather E Barry1, Carmel M Hughes3. 1. Primary Care Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, Northern Ireland, BT9 7BL, UK. 2. The School of Pharmacy and Pharmaceutical Sciences, Panoz Institute, Trinity College Dublin, Dublin 2, Ireland. 3. Primary Care Research Group, School of Pharmacy, Medical Biology Centre, Queen's University Belfast, 97 Lisburn Road, Belfast, Northern Ireland, BT9 7BL, UK. c.hughes@qub.ac.uk.
Abstract
BACKGROUND: The importance of optimising medicines management for people with dementia has been emphasised through research and policy. However, evidence is currently lacking regarding how to achieve this in this patient population. OBJECTIVE: The aim was to assess the effectiveness of medicines management interventions for people with dementia living in their own home or a care home, with or without nursing care. METHODS: A systematic literature search was conducted in February 2016 across six electronic databases and three trial registries. Inclusion criteria were randomised controlled trials of medicines management (prescribing, dispensing, adherence, and/or review) interventions for people with dementia living in their own homes or care homes, with or without nursing. An assessment of quality was conducted for all studies, using the Cochrane tool for assessing the risk of bias. All outcomes were considered using a narrative approach. RESULTS: Overall, 1365 articles were identified, with three studies eligible for inclusion (n = 475 participants). The studies were heterogeneous both in terms of intervention components, setting, and outcomes used. Aspects of medicines management targeted included medication review, adherence, and administration. Improvements in psychotropic prescribing were observed; however, the interventions had limited effects on other outcomes such as wellbeing, falls and dementia severity. CONCLUSION: This review highlights the limited number of studies examining medicines management interventions for people with dementia. Of the work that has been conducted to date, emphasis has been placed on psychotropic drug use. Future research must target community-dwelling dementia patients and take a holistic approach to medicines management.
BACKGROUND: The importance of optimising medicines management for people with dementia has been emphasised through research and policy. However, evidence is currently lacking regarding how to achieve this in this patient population. OBJECTIVE: The aim was to assess the effectiveness of medicines management interventions for people with dementia living in their own home or a care home, with or without nursing care. METHODS: A systematic literature search was conducted in February 2016 across six electronic databases and three trial registries. Inclusion criteria were randomised controlled trials of medicines management (prescribing, dispensing, adherence, and/or review) interventions for people with dementia living in their own homes or care homes, with or without nursing. An assessment of quality was conducted for all studies, using the Cochrane tool for assessing the risk of bias. All outcomes were considered using a narrative approach. RESULTS: Overall, 1365 articles were identified, with three studies eligible for inclusion (n = 475 participants). The studies were heterogeneous both in terms of intervention components, setting, and outcomes used. Aspects of medicines management targeted included medication review, adherence, and administration. Improvements in psychotropic prescribing were observed; however, the interventions had limited effects on other outcomes such as wellbeing, falls and dementia severity. CONCLUSION: This review highlights the limited number of studies examining medicines management interventions for people with dementia. Of the work that has been conducted to date, emphasis has been placed on psychotropic drug use. Future research must target community-dwelling dementiapatients and take a holistic approach to medicines management.
Authors: Jennifer H Lingler; Susan M Sereika; Carolyn M Amspaugh; Janet A Arida; Mary E Happ; Martin P Houze; Robert R Kaufman; Melissa L Knox; Lisa K Tamres; Fengyan Tang; Judith A Erlen Journal: Geriatr Nurs Date: 2016-01-21 Impact factor: 2.361
Authors: Ingelin Testad; Ann Corbett; Dag Aarsland; Kristin Osland Lexow; Jane Fossey; Bob Woods; Clive Ballard Journal: Int Psychogeriatr Date: 2014-02-24 Impact factor: 3.878
Authors: Jo Thompson Coon; Rebecca Abbott; Morwenna Rogers; Rebecca Whear; Stephen Pearson; Iain Lang; Nick Cartmell; Ken Stein Journal: J Am Med Dir Assoc Date: 2014-08-08 Impact factor: 4.669
Authors: Paula R Williamson; Douglas G Altman; Jane M Blazeby; Mike Clarke; Declan Devane; Elizabeth Gargon; Peter Tugwell Journal: Trials Date: 2012-08-06 Impact factor: 2.279
Authors: Heather E Barry; Laura E Bedford; Máiréad McGrattan; Cristín Ryan; A Peter Passmore; A Louise Robinson; Gerard J Molloy; Carmel M Darcy; Hilary Buchanan; Carmel M Hughes Journal: BMC Health Serv Res Date: 2020-02-14 Impact factor: 2.655
Authors: Usman Talat; Kelly Ann Schmidtke; Saval Khanal; Amy Chan; Alice Turner; Robert Horne; Tim Chadborn; Natalie Gold; Anna Sallis; Ivo Vlaev Journal: Front Pharmacol Date: 2022-01-25 Impact factor: 5.810
Authors: Sue Jordan; Timothy Banner; Marie Gabe-Walters; Jane M Mikhail; Gerwyn Panes; Jeff Round; Sherrill Snelgrove; Mel Storey; David Hughes Journal: PLoS One Date: 2019-09-11 Impact factor: 3.240